Position in ILMN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$444,146
-$506,230 QoQ
Shares Held
2,526
-64.5% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#580
of 932 holders
Holding Since
Jun 2020
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ILMN Over Time
Shares Held
Position Value (USD)
Derivatives in ILMN
reported options exposure · as of Dec 31, 2022CallValue
$0
CallShares
0
PutValue
$2,001,779
PutShares
10,177
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Laurion Capital Management LP holds $954,548 across 2 Diagnostics & Research names. ILMN ranks #2 (46.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GH |
Guardant Health, Inc.
|
3,402 | $510,402 | |
| 2 | ILMN |
Illumina, Inc.
This page
|
2,526 | $444,146 |
All Filings in ILMN
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $444,146 | 2,526 | Shares | Sole | 2026-08-13 | |
| 2024-12-31 | $950,376 | 7,112 | Shares | Sole | 2025-02-14 | |
| 2022-12-31 | $2,001,779 | 9,900 | Put | Sole | 2023-02-14 | |
| 2022-12-31 | $1,520,543 | 7,520 | Shares | Sole | 2023-02-14 | |
| 2021-09-30 | $938,581 | 2,314 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,145,641 | 2,421 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $888,714 | 2,314 | Shares | Sole | 2021-05-14 | |
| 2020-09-30 | $2,468,622 | 7,987 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $740,699 | 2,000 | Put | Sole | 2020-08-14 | |
| 2020-06-30 | $1,518,434 | 4,100 | Call | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||